[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"steroid-injection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:steroid-injection":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,55],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100622587","the-importance-of-adding-fenestration-to-ultrasound-guided-bakers-cyst-aspiration-100622587",false,"NCT07385560","\"The Importance of Adding Fenestration to Ultrasound-Guided Baker's Cyst Aspiration\"","Inclusion Criteria:\n\n* Adults aged 40 to 75 years\n* Diagnosis of knee osteoarthritis according to the 2010 American College of Rheumatology (ACR) criteria\n* Presence of a symptomatic Baker's cyst confirmed by ultrasonography\n* Ability to understand study procedures and provide written informed consent\n* Sufficient intellectual and social capacity to comply with study visits and follow-up requirements\n\nExclusion Criteria:\n\n* Presence of inflammatory arthritis, septic arthritis, crystal arthropathy, or secondary causes of knee osteoarthritis\n* Kellgren-Lawrence grade 4 knee osteoarthritis\n* Active systemic infection\n* History of malignancy\n* Intra-articular knee injection within the past 3 months\n* Knee trauma within the past 3 months\n* History of knee surgery\n* Contraindications to aspiration or corticosteroid injection (e.g., local infection, bleeding disorders, uncontrolled diabetes mellitus)\n* Requirement to continue medications for inflammatory arthritis\n* Diagnosed psychiatric disorder that may impair study participation\n* Use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the past 1 week\n* Physical therapy applied to the knee region within the past 1 month","ALL","40 Years","75 Years",{"count":19,"type":20},44,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to evaluate whether adding a fenestration procedure to standard ultrasound-guided aspiration and corticosteroid-lidocaine injection provides additional clinical benefits for patients with symptomatic Baker's cyst associated with knee osteoarthritis. Baker's cyst is a fluid-filled swelling located behind the knee that may cause pain, stiffness, swelling, and limited mobility. Although aspiration with medication injection is commonly used to relieve symptoms, recurrence of the cyst is frequent.\n\nFenestration is a minimally invasive technique in which small controlled openings are created in the cyst wall under ultrasound guidance to improve internal drainage and potentially reduce recurrence. In this prospective, randomized, double-blind, controlled study, participants will be assigned to one of two groups:\n\n1. aspiration with corticosteroid and lidocaine injection, or\n2. aspiration with corticosteroid and lidocaine injection plus fenestration.\n\nPain, functional scores, cyst measurements, and recurrence will be assessed at follow-up visits at 2 weeks, 1 month, and 3 months. The purpose of this study is to determine whether the addition of fenestration results in better symptom improvement and lower rates of recurrence compared with standard aspiration alone.",[26,27,28,29,30,31],"Baker Cyst","Fenestration","Musculoskeletal Ultrasound","Steroid Injection","OMERACT","Knee Osteoarthritis",[33,34,35,36,37,27,30,38,39,40,41],"Baker's cyst","Knee osteoarthritis","Ultrasound-guided aspiration","Steroid injection","Lidocaine","WOMAC","Musculoskeletal ultrasound","Cyst recurrence","KOOS","NOT_YET_RECRUITING","2026-01-29",{"date":45,"type":46},"2026-02-04","ACTUAL",{"date":48,"type":20},"2026-02-15",{"date":50,"type":20},"2026-05-30",{"name":52,"class":53},"Istanbul University - Cerrahpasa","OTHER",1,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":4,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":15,"minAge":62,"maxAge":4,"enrollmentInfo":63,"targetDuration":4,"studyType":21,"phases":65,"briefSummary":66,"conditions":67,"keywords":70,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":4},"100550939","efficacy-of-platelet-rich-plasma-injection-compare-with-corticosteroid-in-pes-anserinus-pain-syndrome-100550939","NCT06453603","Efficacy of Platelet-rich Plasma Injection Compare With Corticosteroid in Pes Anserinus Pain Syndrome","Efficacy of Platelet-rich Plasma Injection Compare With Corticosteroid in Pes Anserinus Pain Syndrome, Randomized Controlled Trial Study","Inclusion Criteria\n\n* Over 18 years old\n* Patients diagnosed with Pes Anserine Pain Syndrome\n* Patients willing to participate in the research project by signing a consent form\n\nExclusion Criteria:\n\n* Patients with a localized knee infection or a disseminated infection within the past 3 months\n* Patients with thyroid disorders, rheumatoid arthritis, or other types of knee arthritis\n* Patients with abnormal blood coagulation or thrombocytopenia\n* Patients who are pregnant\n* Patients with any type of cancer\n* Patients who cannot follow up with treatment until the end of the project\n* Patients who are unwilling to participate in the project or wish to withdraw from the research project","18 Years",{"count":64,"type":20},24,[23],"The goal of this research is to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis. The research question is whether PRP can reduce pain more effectively than corticosteroids.\n\nThe study is divided into two groups: one group receiving PRP injections and the second group receiving corticosteroid injections. Treatment outcomes will be monitored at four time points: baseline, 4 weeks, 12 weeks, and 24 weeks. The outcomes will be measured using the VAS and WOMAC scores.",[68,29,69],"Pes Anserine Bursitis","PRP Injection",[68,29,71],"PRP injection","2024-06-10",{"date":74,"type":46},"2024-06-11",{"date":76,"type":20},"2024-07-01",{"date":78,"type":20},"2026-12-31",{"name":80,"class":53},"Ramathibodi Hospital"]